Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $5.03
- Average 1Y price target
- $9.50+88.87%
- Agreement
- Good
Analysts agreement range is spread less than 15% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall1
- DCF1
- Return on equity4
- Return on assets1
- Debt / equity1
- P/E1
- P/B1
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 0 | — |
| Last quarter | 0 | — |
| Last year | 4 | $13.13 |
| All time | 6 | $12.92 |
Recent rating changes
The latest 35 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 20, 2026 | Ascendiant Capital | maintain | Buy | Buy |
| May 22, 2026 | Ascendiant Capital | maintain | Buy | Buy |
| Apr 24, 2026 | Barrington Research | maintain | Outperform | Outperform |
| Feb 20, 2026 | Barrington Research | maintain | Outperform | Outperform |
| Nov 19, 2025 | Ascendiant Capital | maintain | Buy | Buy |
| Oct 29, 2025 | Barrington Research | maintain | Outperform | Outperform |
| Aug 26, 2025 | Ascendiant Capital | maintain | Buy | Buy |
| Jul 24, 2025 | Barrington Research | maintain | Outperform | Outperform |
| May 30, 2025 | Ascendiant Capital | maintain | Buy | Buy |
| Apr 29, 2025 | Barrington Research | maintain | Outperform | Outperform |
| Apr 23, 2025 | Barrington Research | maintain | Outperform | Outperform |
| Feb 25, 2025 | Barrington Research | maintain | Outperform | Outperform |
| Nov 11, 2024 | Ascendiant Capital | maintain | Buy | Buy |
| Oct 24, 2024 | Barrington Research | maintain | Outperform | Outperform |
| Oct 22, 2024 | Barrington Research | maintain | Outperform | Outperform |
| Aug 19, 2024 | Ascendiant Capital | maintain | Buy | Buy |
| Jul 26, 2024 | Barrington Research | maintain | Outperform | Outperform |
| Jul 15, 2024 | Barrington Research | maintain | Outperform | Outperform |
| Apr 24, 2024 | Barrington Research | maintain | Outperform | Outperform |
| Feb 29, 2024 | Barrington Research | maintain | Outperform | Outperform |
| Jul 28, 2023 | Barrington Research | maintain | Outperform | Outperform |
| Apr 28, 2023 | Barrington Research | upgrade | Market Perform | Outperform |
| Jul 29, 2022 | Barrington Research | maintain | Outperform | Outperform |
| Apr 23, 2021 | Noble Capital Markets | upgrade | Market Perform | Outperform |
| Mar 26, 2021 | Ascendiant Capital | upgrade | Hold | Buy |
| Mar 18, 2021 | Noble Capital Markets | downgrade | Outperform | Market Perform |
| Jul 24, 2020 | Barrington Research | maintain | Outperform | Outperform |
| Mar 1, 2016 | Macquarie | maintain | Neutral | Neutral |
| Oct 17, 2014 | Benchmark | maintain | Hold | Hold |
| Jul 18, 2014 | Benchmark | maintain | Hold | Hold |
| Apr 19, 2013 | Ascendiant Capital | maintain | Neutral | Neutral |
| Oct 15, 2012 | Benchmark | maintain | Hold | Hold |
| Oct 15, 2012 | Ascendiant Capital | downgrade | Buy | Neutral |
| Oct 4, 2012 | Benchmark | maintain | Hold | Hold |
| Oct 4, 2012 | Ascendiant Capital | maintain | Buy | Buy |